Skip to main content
logo
Verastem, Inc. (VSTM)
NASDAQ: VSTM · Real-Time Price · USD
3.475
+0.025 (0.72%)
Jun 26, 2026, 9:38 AM EDT - Market open

Verastem Revenue

Verastem had revenue of $18.67M in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to $49.59M, up 395.85% year-over-year. In the year 2025, Verastem had annual revenue of $30.91M with 209.14% growth.

Revenue (ttm)
$49.59M
Revenue Growth
+395.85%
P/S Ratio
6.11
Revenue / Employee
$486,127
Employees
102
Market Cap
305.36M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202530.91M20.91M209.14%
Dec 31, 202410.00M--
Dec 31, 2023---
Dec 31, 20222.60M543.00K26.45%
Dec 31, 20212.05M-86.46M-97.68%
Dec 31, 202088.52M71.06M407.08%
Dec 31, 201917.46M-9.26M-34.67%
Dec 31, 201826.72M--
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Vanda Pharmaceuticals217.78M
Fennec Pharmaceuticals51.00M
X4 Pharmaceuticals9.01M
Upstream Bio3.32M
Compass Therapeutics850.00K
Silence Therapeutics839.00K
Revenue Rankings

VSTM News

More News